Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Respinor
Oslo, Norwayrespinor.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Respinor has developed DXT, a novel non-invasive ultrasound-based medical device that enables continuous and operator-independent monitoring of the diaphragm in critically ill patients. The technology has completed key clinical studies demonstrating its ability to identify patients at increased risk of weaning failure from mechanical ventilation. The company has secured significant European funding and aims to obtain regulatory approval in both the EU and US markets. Clinical results support its use for early detection of diaphragm dysfunction to improve outcomes during critical care.
- Therapeutic areas
- Pulmonology
- Modalities
- DeviceNon-pharmacological therapy (monitoring)Ultrasound-based device
- Industry
- Medical Imaging
02
Partnerships
Secured substantial funding from Horizon2020 SME Instrument/EU Commission and The Research Council of Norway; no major pharma or medtech partnerships disclosed.
Beyond the preview
Go deeper on Respinor.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Respinor.